Holen Sie sich die Stockscreener-App
3.15
0.63%
-0.02
Handel nachbörslich:
3.15
Schlusskurs vom Vortag:
$3.17
Offen:
$3.2
24-Stunden-Volumen:
101.53K
Relative Volume:
0.36
Marktkapitalisierung:
$121.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-42.05M
KGV:
-1.117
EPS:
-2.82
Netto-Cashflow:
$-35.26M
1W Leistung:
+0.96%
1M Leistung:
+0.00%
6M Leistung:
-13.22%
1J Leistung:
+65.79%
1-Tages-Spanne:
$3.13
$3.29
1-Wochen-Bereich:
$3.1042
$3.30
52-Wochen-Spanne:
$1.595
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
Firmenname
Protara Therapeutics Inc
Sektor
Branche
Telefon
646-844-0337
Adresse
345 PARK AVENUE SOUTH, NEW YORK, NY
Vergleichen Sie TARA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
3.15 | 122.30M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-03-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-10 | Fortgesetzt | Guggenheim | Buy |
| 2021-06-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-02-17 | Eingeleitet | Oppenheimer | Outperform |
| 2020-10-19 | Eingeleitet | Cowen | Outperform |
| 2020-07-29 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Protara Therapeutics Inc Aktie (TARA) Neueste Nachrichten
What data driven models say about Protara Therapeutics Inc.’s futureBear Alert & Comprehensive Market Scan Reports - Newser
Candlestick signals on Protara Therapeutics Inc. stock today2025 Price Targets & Safe Entry Trade Signal Reports - Newser
Full technical analysis of Protara Therapeutics Inc. stockWatch List & High Accuracy Swing Entry Alerts - Newser
Can Protara Therapeutics Inc. ride the EV waveWeekly Trade Recap & Capital Protection Trading Alerts - خودرو بانک
Can Protara Therapeutics Inc. maintain its current growth rateBond Market & Low Drawdown Momentum Trade Ideas - خودرو بانک
Market reaction to Protara Therapeutics Inc.’s recent newsJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - Newser
Should you hold or exit Protara Therapeutics Inc. now2025 Short Interest & Stepwise Entry/Exit Trade Alerts - Newser
Is Protara Therapeutics Inc. stock a good pick for beginnersIndex Update & Safe Capital Growth Stock Tips - خودرو بانک
How to use Fibonacci retracement on Protara Therapeutics Inc.Weekly Market Outlook & Daily Volume Surge Trade Alerts - Newser
What institutional flow reveals about Protara Therapeutics Inc.2025 Key Lessons & Low Risk High Win Rate Stock Picks - Newser
Combining machine learning predictions for Protara Therapeutics Inc.Bull Run & Expert-Curated Trade Recommendations - Newser
Technical signs of recovery in Protara Therapeutics Inc.Portfolio Risk Report & Fast Exit Strategy with Risk Control - Newser
Published on: 2025-09-04 06:47:02 - Newser
Published on: 2025-09-04 03:23:29 - Newser
How to escape a deep drawdown in Protara Therapeutics Inc.Earnings Beat & AI Optimized Trade Strategies - Newser
Using economic indicators to assess Protara Therapeutics Inc. potentialIndex Update & Reliable Price Breakout Alerts - Newser
Using data filters to optimize entry into Protara Therapeutics Inc.New Guidance & Capital Efficiency Focused Strategies - Newser
How Protara Therapeutics Inc. stock performs during market volatilityEarnings Risk Summary & Long-Term Safe Return Strategies - Newser
Protara Therapeutics shares rise 3.79% intraday after announcing inducement grants to new employees. - AInvest
What Fibonacci levels say about Protara Therapeutics Inc. reboundRisk Management & Real-Time Chart Breakout Alerts - Newser
Published on: 2025-09-02 22:40:30 - Newser
Can momentum traders help lift Protara Therapeutics Inc.2025 Trading Recap & Reliable Breakout Stock Forecasts - Newser
Aug Catalysts: What is Protara Therapeutics Inc.’s TAM (Total Addressable Market)July 2025 Decliners & AI Forecast Swing Trade Picks - خودرو بانک
Protara Therapeutics’ Equity Inducement Grants: A Strategic Catalyst for Talent Retention and Long-Term Value Creation - AInvest
Protara Therapeutics shares fall 1.89% after-hours following inducement grants to new employees. - AInvest
Protara Therapeutics, Inc. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Biotech Firm Protara Therapeutics Issues $3.17/Share Stock Options in Key Employee Compensation Plan - Stock Titan
Published on: 2025-09-02 12:19:22 - Newser
Protara Therapeutics Inc.’s volatility index tracking explainedPortfolio Return Report & AI Powered Trade Plan Recommendations - Newser
Is Protara Therapeutics Inc. vulnerable to short sellers2025 Trading Volume Trends & Intraday High Probability Setup Alerts - خودرو بانک
Is Protara Therapeutics Inc. in a bullish channelTrade Performance Summary & Long-Term Safe Investment Plans - خودرو بانک
What is the earnings history of Protara Therapeutics Inc.2025 Performance Recap & Smart Investment Allocation Tips - خودرو بانک
Published on: 2025-09-02 08:13:43 - خودرو بانک
Is Protara Therapeutics Inc. a top pick in the sectorJuly 2025 Rallies & Expert Approved Momentum Ideas - خودرو بانک
Chartists Watching For Breakout in Protara Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
How to use a screener to detect Protara Therapeutics Inc. breakoutsMarket Activity Recap & Real-Time Volume Analysis - Newser
Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):